Effect of alphavirus vaccine encoding HER2 during concurrent anti-HER2 therapies on induction of oligoclonal T cell and antibody responses against HER2.
Publication
, Conference
Gwin, WR; Hobeika, A; Osada, T; Hartman, Z; Cheng, Q; Broadwater, G; Kimmick, GG; Blackwell, KL; Morse, M; Lyerly, K
Published in: Journal of Clinical Oncology
May 20, 2015
Duke Scholars
Published In
Journal of Clinical Oncology
DOI
EISSN
1527-7755
ISSN
0732-183X
Publication Date
May 20, 2015
Volume
33
Issue
15_suppl
Start / End Page
3081 / 3081
Publisher
American Society of Clinical Oncology (ASCO)
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Gwin, W. R., Hobeika, A., Osada, T., Hartman, Z., Cheng, Q., Broadwater, G., … Lyerly, K. (2015). Effect of alphavirus vaccine encoding HER2 during concurrent anti-HER2 therapies on induction of oligoclonal T cell and antibody responses against HER2. In Journal of Clinical Oncology (Vol. 33, pp. 3081–3081). American Society of Clinical Oncology (ASCO). https://doi.org/10.1200/jco.2015.33.15_suppl.3081
Gwin, William Rayford, Amy Hobeika, Takuya Osada, Zachary Hartman, Qing Cheng, Gloria Broadwater, Gretchen Genevieve Kimmick, Kimberly L. Blackwell, Michael Morse, and Kim Lyerly. “Effect of alphavirus vaccine encoding HER2 during concurrent anti-HER2 therapies on induction of oligoclonal T cell and antibody responses against HER2.” In Journal of Clinical Oncology, 33:3081–3081. American Society of Clinical Oncology (ASCO), 2015. https://doi.org/10.1200/jco.2015.33.15_suppl.3081.
Gwin WR, Hobeika A, Osada T, Hartman Z, Cheng Q, Broadwater G, et al. Effect of alphavirus vaccine encoding HER2 during concurrent anti-HER2 therapies on induction of oligoclonal T cell and antibody responses against HER2. In: Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2015. p. 3081–3081.
Gwin, William Rayford, et al. “Effect of alphavirus vaccine encoding HER2 during concurrent anti-HER2 therapies on induction of oligoclonal T cell and antibody responses against HER2.” Journal of Clinical Oncology, vol. 33, no. 15_suppl, American Society of Clinical Oncology (ASCO), 2015, pp. 3081–3081. Crossref, doi:10.1200/jco.2015.33.15_suppl.3081.
Gwin WR, Hobeika A, Osada T, Hartman Z, Cheng Q, Broadwater G, Kimmick GG, Blackwell KL, Morse M, Lyerly K. Effect of alphavirus vaccine encoding HER2 during concurrent anti-HER2 therapies on induction of oligoclonal T cell and antibody responses against HER2. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2015. p. 3081–3081.
Published In
Journal of Clinical Oncology
DOI
EISSN
1527-7755
ISSN
0732-183X
Publication Date
May 20, 2015
Volume
33
Issue
15_suppl
Start / End Page
3081 / 3081
Publisher
American Society of Clinical Oncology (ASCO)
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences